Mar 7, 2007 by Brian LawlerA CV Therapeutics Buying Opportunity?Shares of CV Therapeutics tank after reporting mixed results from a pivotal clinical trial for its lead drug.
Mar 7, 2007 by Brian LawlerEncysive's Outback AdventuresEncysive gains marketing approval for its lead compound in Australia.
Mar 6, 2007 by Brian LawlerInterMune SwoonsShares of InterMune fall after it announces negative clinical trial results for one of its drugs.
Mar 5, 2007 by Brian LawlerKnow Your Drug Stock ABCs: Part 3Terms and definitions used in the pharmaceutical and biotechnology industries.
Mar 2, 2007 by Brian LawlerVeering ViroPharmaThe drugmaker announces healthier fourth-quarter financial results.
Mar 1, 2007 by Brian LawlerKnow Your Drug Stock ABCs: Part 2Terms investors should know to better understand how the clinical trial process involved with bringing a drug to market works.
Mar 1, 2007 by Brian LawlerKing Atop Its ThroneA surprisingly strong quarter from King Pharmaceuticals.
Mar 1, 2007 by Brian LawlerHospira's Boring GrowthHospira announces its fourth quarter financial results and gives guidance for 2007.
Feb 28, 2007 by Brian LawlerMerck's Mighty FutureMerck ups its 2007 financial forecast, while positive developments occur for two of its most promising new therapies.
Feb 28, 2007 by Brian LawlerPanacos Piles OnThe small drug company tests a revamped treatment for HIV.
Feb 28, 2007 by Brian LawlerTime to Buy Shares of Adolor?Drug developer Adolor announces its fourth-quarter financial results as investors await pivotal clinical trial results.
Feb 28, 2007 by Brian LawlerBarr's Becoming BigGeneric drug producer Barr Pharmaceuticals announces its first quarterly earnings numbers after acquiring Pliva.
Feb 28, 2007 by Brian LawlerNo Dice for NovoNovo Nordisk reports a failed clinical trial for one of its top drugs.
Feb 28, 2007 by Brian LawlerThreshold Over the EdgeThreshold announces negative clinical trial results for its lead drug.
Feb 28, 2007 by Brian LawlerDiscovery Prepares for Its FateDiscovery Labs announces its quarterly financial results as it prepares for another meeting with the FDA.
Feb 28, 2007 by Brian LawlerAlpharma's Just All RightDrugmaker Alpharma announces its fourth-quarter financial results and reiterates guidance for 2007.
Feb 28, 2007 by Brian LawlerDynavax Down but Not OutDrug developer Dynavax gives guidance for 2007 after its lead drug candidate fails in clinical testing.
Feb 28, 2007 by Brian LawlerBristol-Myers Stays Out of TroubleA federal monitor finds Bristol-Myers does not have to pay up over a questionable business deal.
